These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 16240890)

  • 1. [Treatment for HIV infection: 2005 recommendations].
    De Wit S
    Rev Med Brux; 2005 Sep; 26(4):S378-81. PubMed ID: 16240890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health systems and access to antiretroviral drugs for HIV in Southern Africa: service delivery and human resources challenges.
    Schneider H; Blaauw D; Gilson L; Chabikuli N; Goudge J
    Reprod Health Matters; 2006 May; 14(27):12-23. PubMed ID: 16713875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiretrovirals: reality or illusion?
    Mazin R; Zacarias F
    J Int Assoc Physicians AIDS Care; 1998 Oct; 4(10):28-9. PubMed ID: 11365958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent and future therapeutic advances in the management of HIV infection.
    Saliba G; Yeni P
    Pathol Biol (Paris); 2006 Dec; 54(10):545-50. PubMed ID: 17027195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [HIV infection: Which therapeutical challenges remain in 2009?].
    Rouzioux C
    Ann Pharm Fr; 2010 Jan; 68(1):44-6. PubMed ID: 20176162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A survey of the syntheses of active pharmaceutical ingredients for antiretroviral drug combinations critical to access in emerging nations.
    Pinheiro Edos S; Antunes OA; Fortunak JM
    Antiviral Res; 2008 Sep; 79(3):143-65. PubMed ID: 18571246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The evaluation of the HIV/AIDS drug access initiatives in Côte d'Ivoire, Senegal and Uganda: how access to antiretroviral treatment can become feasible in Africa.
    Katzenstein D; Laga M; Moatti JP
    AIDS; 2003 Jul; 17 Suppl 3():S1-4. PubMed ID: 14565603
    [No Abstract]   [Full Text] [Related]  

  • 9. Initiative to promote access to quality HIV medicines releases first batch of results today.
    J Adv Nurs; 2002 Aug; 39(3):215. PubMed ID: 12174834
    [No Abstract]   [Full Text] [Related]  

  • 10. Antiretroviral treatment for HIV infection in developing countries: an attainable new paradigm.
    Moatti JP; N'Doye I; Hammer SM; Hale P; Kazatchkine M
    Nat Med; 2003 Dec; 9(12):1449-52. PubMed ID: 14647513
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment at scale in Brazil: a physician's perspective.
    Schechter M
    AIDS; 2007 Jul; 21 Suppl 4():S31-5. PubMed ID: 17620750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. European Parliament supports treatment access in developing countries.
    James JS
    AIDS Treat News; 2001 Mar; (363):4-5. PubMed ID: 11547677
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-Term suppression of HIV infection: benefits and limitations of current treatment options.
    Sension MG
    J Assoc Nurses AIDS Care; 2007; 18(1 Suppl):S2-10. PubMed ID: 17275719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Africa access: moving fast, outcome uncertain.
    James JS
    AIDS Treat News; 2001 Feb; (360):4-8. PubMed ID: 12173567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AIDS in the Third World: how to stop the HIV infection?
    De Clercq E
    Verh K Acad Geneeskd Belg; 2007; 69(2):65-80. PubMed ID: 17550059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiretroviral drug development: the challenge of cost and access.
    Dunne M
    AIDS; 2007 Jul; 21 Suppl 4():S73-9. PubMed ID: 17620756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New guidelines increase access to HIV/AIDS medication.
    AORN J; 2002 Sep; 76(3):448. PubMed ID: 12382663
    [No Abstract]   [Full Text] [Related]  

  • 19. [Ten years of commitment to persons living with HIV-AIDS: evaluation of the management in three ambulatory treatment centers of the French Red Cross in Africa].
    Mouala C; Madec Y; Adam G; Courpotin C; Fikouma V; Gentilini M; Ould Mohamedoune A; Nzounza P; Schaer E; Simon B; Mattei JF
    Sante; 2008; 18(2):89-95. PubMed ID: 19188132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AIDS, HIV, antiretrovirals and Africa.
    Gazzard B
    J HIV Ther; 2006 Mar; 11(1):4-6. PubMed ID: 16706248
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.